GWMIA
ARTL icon

Global Wealth Management Investment Advisory’s Artelo Biosciences ARTL Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2
Closed – – 485
2021
Q4 		$0 Buy
+2
New +$395 ﹤0.01% 450

Other funds holding ARTL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Global Wealth Management Investment Advisory's ARTL Position: Q1 2022 in Review

Global Wealth Management Investment Advisory sold out of Artelo Biosciences (ARTL) in Q1 2022, closing a stake of 2 shares.

Global Wealth Management Investment Advisory first reported a position in ARTL in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 18 funds tracked by Wall St. Rank hold ARTL as of Q1 2022.

  • Global Wealth Management Investment Advisory reported no remaining Artelo Biosciences position as of Q1 2022 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 2 Artelo Biosciences shares in Q1 2022.
  • Global Wealth Management Investment Advisory first reported a position in Artelo Biosciences in Q4 2021 and held it in 1 quarter.
  • Global Wealth Management Investment Advisory's Artelo Biosciences position peaked at $0 in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2022.

Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2022, filed 17 May 2022.